Hadassah On Call: New Frontiers in Medicine
,
Season
5
,
Episode
12

Immunity Unraveled

In this month's episode Dr. Yuval Tal, director of the Allergy and Clinical Immunology Unit at Hadassah Hospital Ein Kerem shares the latest advancements in clinical immunology, focusing on personalized treatments and biological medicine.

LISTEN NOW

Watch This Episode

IN THIS Episode
Guests

Yuval Tal, MD, PhD

Area of specialty

Internal Medecine

Allergies

Clinical Immunology

Episode Transcript

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C
Text link

Bold text

Emphasis

Superscript

Subscript

Lorem ipsum

Lorem ipsum

About this episode

In this month's episode of Hadassah On Call: New Frontiers in Medicine, we welcome Dr. Yuval Tal, director of the Allergy and Clinical Immunology Unit at Hadassah Hospital Ein Kerem. Dr. Tal shares the latest advancements in clinical immunology, focusing on personalized treatments and biological medicine. He also highlights his department's expertise in treating various immunological diseases.

Dr. Tal discusses his team's recent research on Benralizumab, an IL-5 receptor antibody used to treat eosinophilic cystitis, a rare disease where eosinophils cause bladder inflammation and injury. He shares how his team treated a patient with a bladder condition with an off-label treatment designed for asthma. Within three weeks, the condition started to clear, and after a few months, his cystoscopy came back normal. He also explains his department's collaboration with Harvard University on new research into lupus dermatitis, discussing racial disparities and autoimmune disorders.

Dr. Tal explores potential connections between psychiatric issues and anaphylaxis, a severe allergic reaction, and the link between food allergies and mental health issues in young adults.

What's to come? So much more. As Dr. Tal says, one of the major pieces of research in the works now is how we can potentially replace the EpiPen.

What Else You’ll Hear

  • Is there a link between PTSD and allergies?
  • How Dr. Tal's department is using precision medicine to advance treatments in clinical immunology
  • Is there a specific group of people who may be more susceptible to COVID-19?
  • How are protective antibodies used?

Further learning:


Hadassah On Call: New Frontiers in Medicine is a production of Hadassah, The Women's Zionist Organization of America. Hadassah enhances the health of people around the world through medical education, care and research innovations at the Hadassah Medical Organization. For more information on the latest advances in medicine, please head over to hadassah.org.

Subscribe to our podcast on Apple Podcast, YouTube or your favorite podcast app. If you haven't already, please leave us a review. It only takes a minute, and when you do, it helps others discover Hadassah On Call.

The show is hosted by Maayan Hoffman and produced by the team at the Hadassah offices in New York and Israel.

This episode includes promotions for:

Our recent episode with Dr. David Hakimian
If you are enjoying this episode, you’ll want to check out our previous episode with Dr. David Hakimian, a senior gastroenterologist at the Hadassah Medical Organization. Dr. Hakimian discusses some of the most common indicators of serious health issues including symptoms, ways to improve and much more.

You can find that episode of Hadassah On Call on Apple Podcasts, Google Play or wherever you get your podcast. Or on the web at hadassah.org/hadassahoncall.

Gandel Rehabilitation Center at Hadassah Mount Scopus
Israel is facing a critical shortage in rehabilitation capacity, especially in Jerusalem, at a time when it is most needed. Since October 7, more than 15,000 Israelis have been wounded in Hamas' terrorist attacks.

The world-class Gandel Rehabilitation Center at Hadassah Hospital Mount Scopus opened three floors early to meet Israel’s rehab needs after October 7. You can still help advance the second phase of construction to serve 10,000 patients a year by donating at go.hadassah.org/GRC.

About our guest(s)

Yuval Tal, MD, PhD, is a specialist in internal medicine, allergy and clinical immunology and the director of the Allergy and Clinical Immunology Unit at Hadassah Hospital Ein Kerem. Dr. Tal finished his PhD dissertation in the molecular biology department of the Hadassah-Hebrew University School of Medicine in 2004 after completing his BSc in Biology from Tel Aviv University and MSc from the Hadassah-Hebrew University School of Medicine.

In addition to national and international positions, Dr. Tal is the director of the Occupational Health Unit and chair of the Hadassah hospital off-label drug therapy committee. He teaches multiple courses at Hebrew University of Jerusalem and is a consultant to the Israel Ministry of Health. Secretary of the Israeli Allergy & Clinical Immunology Association, Dr. Tal leads one of the biggest clinical immunology units in Israel with extensive clinical studies and basic research. Dr. Tal has published in leading medical journals on a range of topics within clinical immunology, from molecular immunology and immune deficiencies to autoimmunity and allergy. He has presented in multiple national and international professional conferences.